Evidence map›Paper›PMID 40570851›Full record

ArticleImmunity2025

Prolonged but finite antigen presentation promotes reversible defects of "helpless" memory CD8

Verena van der Heide, Gabriel Laghlali, Bennett Davenport, Beatrice Cubitt, Vladimir Roudko, Daniel Choo, Kevin Jhun, Etienne Humblin, Abishek Vaidya, Krista Angeliadis and 7 more

Abstract read
In one paragraph

Article in Immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Verena van der HeideMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA. Electronic address: verena.vanderheide@mssm.edu.
Gabriel LaghlaliDepartment of Microbiology, ISMMS, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, ISMMS, New York, NY 10029, USA; Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium.
Bennett DavenportMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Beatrice CubittDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Vladimir RoudkoMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA; Human Immune Monitoring Center, ISMMS, New York, NY 10029, USA.
Daniel ChooEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Kevin JhunMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA.
Etienne HumblinMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA.
Abishek VaidyaMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA.
Krista AngeliadisHuman Immune Monitoring Center, ISMMS, New York, NY 10029, USA.
Travis DawsonHuman Immune Monitoring Center, ISMMS, New York, NY 10029, USA.
Glaucia FurtadoMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA.
Alice O KamphorstMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA; Department of Oncological Sciences, ISMMS, New York, NY 10029, USA; Tisch Cancer Institute, ISMMS, New York, NY 10029, USA.
Michael SchotsaertMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA; Department of Microbiology, ISMMS, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, ISMMS, New York, NY 10029, USA; Icahn Genomics Institute, ISMMS, New York, NY 10029, USA.
Rafi AhmedEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Juan Carlos de la TorreDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Dirk HomannMarc and Jennifer Lipschultz Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY 10029, USA; Diabetes, Obesity and Metabolism Institute, Department of Medicine, ISMMS, New York, NY 10029, USA. Electronic address: dxh2185@miami.edu.

Funding

Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacyR01AI160706 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHOTSAERT, MICHAEL, WONG, PAMELA TINMOI · 2022 to 2025
$2.9M
Molecular Pathogenesis of Infectious DiseasesT32AI052066 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2002 to 2022
$2.3M
TRAINING PROGRAM IN INVESTIGATIVE GASTROENTEROLOGYT32DK007792 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CHO, JUDY H. · 2001 to 2016
$2.3M
Regulation of Pathogen-specific T Cell Immunity by Adenosine GenerationR01AI093637 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOMANN, DIRK · 2012 to 2016
$2.0M
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccinationR44AI176894 · NIAID · 7 HILLS PHARMA, LLC · PI DE, SIDDHARTHA, MARATHI, UPENDRA · 2023 to 2024
$1.9M
T Cell Memory to VirusesR01AI186330 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2024 to 2026
$1.9M
Roles of the Nucleoprotein 3'-5' Exonuclease Domain in Arenavirus BiologyR01AI142985 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DE LA TORRE, JUAN C., MARTINEZ-SOBRIDO, LUIS · 2019 to 2022
$1.8M
Experimental and natural SARS-CoV-2 infection of the human pancreasR01DK130425 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOMANN, DIRK, SCHOTSAERT, MICHAEL · 2021 to 2023
$1.3M
A General Molecular Strategy for Attenuation of Human Pathogenic ArenavirusesR21AI121840 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DE LA TORRE, JUAN C. · 2016 to 2017
$529k
Designing mammarenavirus live vaccines with unbreachable attenuationR21AI169789 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DE LA TORRE, JUAN C. · 2022 to 2023
$488k
Impact of mucosal adjuvanted vaccines on virus transmission in preclinical animal models for SARS-CoV-2 and influenza virus infectionR21AI180874 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHOTSAERT, MICHAEL, WONG, PAMELA TINMOI · 2024 to 2025
$472k
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunityR21AI176069 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHOTSAERT, MICHAEL, WONG, PAMELA TINMOI · 2023 to 2024
$466k
NIAID NIH HHS R01 AI093637NIAID NIH HHS R01 AI142985NIAID NIH HHS R01 AI160706NIAID NIH HHS R01 AI186330NIAID NIH HHS R21 AI121840NIAID NIH HHS R21 AI169789NIAID NIH HHS R21 AI176069NIAID NIH HHS R21 AI180874NIAID NIH HHS R44 AI176894NIAID NIH HHS T32 AI052066NIDDK NIH HHS R01 DK130425NIDDK NIH HHS T32 DK007792
6 · The paper itself

Abstract

Generation of functional memory CD8

Indexed as

Antigen PresentationCD8-Positive T-LymphocytesImmunologic MemoryMemory T CellsAnimalsCell DifferentiationHepatocyte Nuclear Factor 1-alphaLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicHepatocyte Nuclear Factor 1-alphaHnf1a protein, mouseacute infectionCD4(+) T cell helpCD8(+) T cell memory“helpless” memoryinfluenza A virusListeria monocytogeneslymphocytic choriomeningitis virusvaccinia virus

Identifiers

PMID40570851
PMCPMC12424618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.